(Q42825153)

8 November 2017

title

Simvastatin enhances induction of inducible nitric oxide synthase in 3T3-L1 adipocytes (English)

1 reference

8 November 2017

1 reference

1 reference

Shunsuke Araki

1

1 reference

8 November 2017

Kazushige Dobashi

series ordinal

2

1 reference

8 November 2017

Kohtaro Asayama

series ordinal

3

1 reference

8 November 2017

Akira Shirahata

series ordinal

4

1 reference

8 November 2017

publication date

1 September 2007

1 reference

8 November 2017

published in

Free Radical Research

1 reference

8 November 2017

volume

41

1 reference

8 November 2017

issue

9

1 reference

8 November 2017

page(s)

1028-1034

1 reference

Nitric oxide synthases: Roles, tolls, and controls

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

The reaction of no with superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Differential effects of cyclic AMP on induction of nitric oxide synthase in 3T3-L1 cells and brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Statin blocks Rho/Rho-kinase signalling and disrupts the actin cytoskeleton: relationship to enhancement of LPS-mediated nitric oxide synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Analysis of an expression profile of genes in the human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Different effect induced by treatment with several statins on monocyte tissue factor expression in hypercholesterolemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Role of Rho-kinase in regulation of insulin action and glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760701534368

10.1080/10715760701534368

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference